MRNA - Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge | Benzinga

A Delaware District Court sided with Arbutus Biopharma Corporation (NASDAQ:ABUS) and Genevant Sciences in their ongoing patent infringement case against Moderna Inc (NASDAQ:MRNA) COVID-19 vaccine.

The companies jointly submitted a claim construction brief to the Delaware district court, seeking clarification on the patent’s contested terms. They aim to define the meaning and extent of their patent claims precisely.

The District Court of Delaware released its decision on Wednesday, April 3.

Through the Full story available on Benzinga.com